These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 22609259

  • 1. The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men.
    Fu CP, Lee IT, Sheu WH, Lee WJ, Liang KW, Lee WL, Lin SY.
    Clin Chim Acta; 2012 Oct 09; 413(19-20):1647-51. PubMed ID: 22609259
    [Abstract] [Full Text] [Related]

  • 2. Weight loss reduces serum monocyte chemoattractant protein-1 concentrations in association with improvements in renal injury in obese men with metabolic syndrome.
    Fu CP, Sheu WH, Lee IT, Lee WJ, Wang JS, Liang KW, Lee WL, Lin SY.
    Clin Chem Lab Med; 2015 Mar 09; 53(4):623-9. PubMed ID: 25301674
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
    Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE, Kwon BS, Erickson KL, Yu R.
    Int J Obes (Lond); 2006 Sep 09; 30(9):1347-55. PubMed ID: 16534530
    [Abstract] [Full Text] [Related]

  • 4. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
    Sato H, Kuroda T, Tanabe N, Ajiro J, Wada Y, Murakami S, Sakatsume M, Nakano M, Gejyo F.
    Scand J Rheumatol; 2010 Sep 09; 39(1):33-7. PubMed ID: 20132068
    [Abstract] [Full Text] [Related]

  • 5. Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.
    Satoh-Asahara N, Suganami T, Majima T, Kotani K, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Himeno A, Kono S, Sugawara A, Hattori M, Ogawa Y, Shimatsu A, Japan Obesity and Metabolic Syndrome Study (JOMS) Group.
    Clin J Am Soc Nephrol; 2011 Feb 09; 6(2):265-73. PubMed ID: 21051748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].
    Hu WH, Qiao J, Li MZ.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 20; 87(11):721-4. PubMed ID: 17565837
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K, Matsumoto S, Aso Y, Inukai T.
    J Diabetes Complications; 2006 Mar 20; 20(2):98-104. PubMed ID: 16504838
    [Abstract] [Full Text] [Related]

  • 10. [Association of albuminuria with adipokines, inflammation and insulin resistance in non-diabetic subjects].
    Vasilescu R, Ionescu-Tîrgovişte C.
    Rev Med Chir Soc Med Nat Iasi; 2011 Mar 20; 115(4):1174-82. PubMed ID: 22276466
    [Abstract] [Full Text] [Related]

  • 11. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
    Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA.
    Nephrol Dial Transplant; 1996 Jun 20; 11(6):1096-103. PubMed ID: 8671975
    [Abstract] [Full Text] [Related]

  • 12. Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
    Chiang WC, Lin SL, Chen YM, Wu KD, Tsai TJ.
    Nephrology (Carlton); 2008 Jun 20; 13(3):198-203. PubMed ID: 18315702
    [Abstract] [Full Text] [Related]

  • 13. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients.
    Tretjakovs P, Jurka A, Bormane I, Mackevics V, Mikelsone I, Balode L, Reihmane D, Stukena I, Bahs G, Aivars JI, Pirags V.
    Eur J Intern Med; 2009 Nov 20; 20(7):712-7. PubMed ID: 19818293
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity.
    Schernthaner GH, Kopp HP, Kriwanek S, Krzyzanowska K, Satler M, Koppensteiner R, Schernthaner G.
    Obes Surg; 2006 Jun 20; 16(6):709-15. PubMed ID: 16756729
    [Abstract] [Full Text] [Related]

  • 16. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
    Chacón MR, Fernández-Real JM, Richart C, Megía A, Gómez JM, Miranda M, Caubet E, Pastor R, Masdevall C, Vilarrasa N, Ricard W, Vendrell J.
    Obesity (Silver Spring); 2007 Mar 20; 15(3):664-72. PubMed ID: 17372317
    [Abstract] [Full Text] [Related]

  • 17. Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects.
    Hashimoto I, Wada J, Hida A, Baba M, Miyatake N, Eguchi J, Shikata K, Makino H.
    Obesity (Silver Spring); 2006 May 20; 14(5):799-811. PubMed ID: 16855189
    [Abstract] [Full Text] [Related]

  • 18. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
    Tam FW, Sanders JS, George A, Hammad T, Miller C, Dougan T, Cook HT, Kallenberg CG, Gaskin G, Levy JB, Pusey CD.
    Nephrol Dial Transplant; 2004 Nov 20; 19(11):2761-8. PubMed ID: 15353578
    [Abstract] [Full Text] [Related]

  • 19. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
    Kiani AN, Johnson K, Chen C, Diehl E, Hu H, Vasudevan G, Singh S, Magder LS, Knechtle SJ, Petri M.
    J Rheumatol; 2009 Oct 20; 36(10):2224-30. PubMed ID: 19648301
    [Abstract] [Full Text] [Related]

  • 20. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
    Hu W, Qiao J, Yang Y, Wang L, Li R.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul 20; 157(1):53-6. PubMed ID: 21530057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.